Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01771497 · ClinicalTrials.gov registry record
Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring
A clinical trial, sponsored by Koning Corporation.
- Completed
- Registry status
- 12
- Enrollment target
NCT01771497: Completed study, sponsored by Koning Corporation.
NCT01771497 is a clinical trial that has completed, run by Koning Corporation. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01771497 has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The hypothesis of this study is that using Koning Breast CT during the neoadjuvant treatment of breast cancer will allow for accurate tumor localization and tumor volume measurement, leading to improved surgical and radiation therapy outcomes.
Interventions
- DEVICE Koning Breast CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01771497
The ClinicalTrials.gov registry entry for NCT01771497 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Koning Corporation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Koning Breast CT is the first listed.
NCT01771497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01771497 about?
NCT01771497 is a clinical study titled "Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring". The hypothesis of this study is that using Koning Breast CT during the neoadjuvant treatment of breast cancer will allow for accurate tumor localization and tumor volume measurement, leading to improved surgical and radiation therapy outcomes.
What is the current status of trial NCT01771497?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2010-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01771497?
The interventions under investigation include: Koning Breast CT (DEVICE).
Who is sponsoring clinical trial NCT01771497?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.